Proposed Information Collection (Disability Benefits Questionnaires-Group 4) Activity: Comment Request, 45008-45009 [2011-18958]
Download as PDF
<![CDATA[
sroberts on DSK5SPTVN1PROD with NOTICES
45008
Federal Register / Vol. 76, No. 144 / Wednesday, July 27, 2011 / Notices
As so prefaced, the Commission has
identified the following tentative
priorities:
(1) Continuation of its work on
statutory mandatory minimum
penalties, including (A) its study of and,
pursuant to the directive in section 4713
of the Matthew Shepard and James
Byrd, Jr. Hate Crimes Prevention Act of
2009, Public Law 111B84, report to
Congress on statutory mandatory
minimum penalties, including a review
of the operation of the ‘‘safety valve’’
provision at 18 U.S.C. 3553(e); and (B)
its study of and, pursuant to the
directive in section 107(b) of the
Comprehensive Iran Sanctions,
Accountability, and Divestment Act of
2010, Public Law 111B195, report to
Congress regarding violations of section
5(a) of the United Nations Participation
Act of 1945 (22 U.S.C. 287c(a)), sections
38, 39, and 40 of the Arms Export
Control Act (22 U.S.C. 2778, 2779, and
2780), and the Trading with the Enemy
Act (50 U.S.C. App. 1 et seq.).
(2) Continuation of its work on
implementation of the directives in
section 1079A of the Dodd-Frank Wall
Street Reform and Consumer Protection
Act, Public Law 111B203, regarding
securities fraud offenses and fraud
offenses relating to financial institutions
or Federally related mortgage loans; and
implementation of any other crime
legislation enacted during the 111th or
112th Congress warranting a
Commission response.
(3) Continuation of its work with the
congressional, executive, and judicial
branches of government, and other
interested parties, to study the manner
in which United States v. Booker, 543
U.S. 220 (2005), and subsequent
Supreme Court decisions have affected
Federal sentencing practices, the
appellate review of those practices, and
the role of the Federal sentencing
guidelines. The Commission anticipates
that it will issue a report with respect
to its findings, possibly including (A)
An evaluation of the impact of those
decisions on the Federal sentencing
guideline system; (B) development of
recommendations for legislation
regarding Federal sentencing policy; (C)
an evaluation of the appellate standard
of review applicable to post-Booker
Federal sentencing decisions; and (D)
possible consideration of amendments
to the Federal sentencing guidelines.
(4) Continuation of its multi-year
review of § 2D1.1 (Unlawful
Manufacturing, Importing, Exporting, or
Trafficking (Including Possession with
Intent to Commit These Offenses);
Attempt or Conspiracy) and possible
consideration of amendments to the
VerDate Mar<15>2010
17:08 Jul 26, 2011
Jkt 223001
Federal sentencing guidelines for drug
offenses.
(5) Continuation of its review of child
pornography offenses and report to
Congress as a result of such review. It
is anticipated that any such report
would include (A) A review of the
incidence of, and reasons for, departures
and variances from the guideline
sentence; (B) a compilation of studies
on, and analysis of, recidivism by child
pornography offenders; and (C) possible
recommendations to Congress on any
statutory changes that may be
appropriate.
(6) Continuation of its multi-year
study of the statutory and guideline
definitions of ‘‘crime of violence’’,
‘‘aggravated felony’’, ‘‘violent felony’’,
and ‘‘drug trafficking offense’’,
including (A) Possible consideration of
an amendment to specify the types of
documents to be considered under the
‘‘categorical approach’’, see Taylor v.
United States, 495 U.S. 575 (1990);
Shepard v. United States, 544 U.S. 13
(2005), for determining the applicability
of guideline enhancements; (B) an
examination of relevant circuit conflicts
regarding whether any offense is
categorically a ‘‘crime of violence’’,
‘‘aggravated felony’’, ‘‘violent felony’’,
or ‘‘drug trafficking offense’’ for
purposes of triggering an enhanced
sentence under certain Federal statutes
and guidelines; and (C) possible report
to Congress making recommendations
on any statutory changes that may be
appropriate to relevant statutes, such as
8 U.S.C. 1326.
(7) Continuation of its review of
departures within the guidelines,
including provisions in Parts H and K
of Chapter Five of the Guidelines
Manual, and the extent to which
pertinent statutory provisions prohibit,
discourage, or encourage certain factors
as forming the basis for departure from
the guideline sentence.
(8) Continuation of its multi-year
review of the guidelines and their
application to human rights offenses,
including genocide under 18 U.S.C.
1091, war crimes under 18 U.S.C. 2441,
torture and maiming to commit torture
under 18 U.S.C. 2340A and 114,
respectively, and child soldier offenses
under 18 U.S.C. 2442, and possible
promulgation of guidelines or guideline
amendments with respect to these
offenses.
(9) Resolution of circuit conflicts,
pursuant to the Commission’s
continuing authority and responsibility,
under 28 U.S.C. 991(b)(1)(B) and
Braxton v. United States, 500 U.S. 344
(1991), to resolve conflicting
interpretations of the guidelines by the
Federal courts.
PO 00000
Frm 00121
Fmt 4703
Sfmt 4703
(10) Consideration of (A) § 5K2.19
(Post-Sentencing Rehabilitative Efforts)
(Policy Statement) in light of Pepper v.
United States, 131 S.Ct. 1229 (March 2,
2011); (B) whether to provide a specific
reference for N-Benzylpiperazine (BZP)
in the Drug Quantity Table in § 2D1.1;
and (C) any other miscellaneous
guideline application issues coming to
the Commission’s attention from case
law and other sources.
The Commission hereby gives notice
that it is seeking comment on these
tentative priorities and on any other
issues that interested persons believe
the Commission should address during
the amendment cycle ending May 1,
2012. To the extent practicable, public
comment should include the following:
(1) A statement of the issue, including,
where appropriate, the scope and
manner of study, particular problem
areas and possible solutions, and any
other matters relevant to a proposed
priority; (2) citations to applicable
sentencing guidelines, statutes, case
law, and constitutional provisions; and
(3) a direct and concise statement of
why the Commission should make the
issue a priority.
Authority: 28 U.S.C. 994(a), (o); USSC
Rules of Practice and Procedure 5.2.
Patti B. Saris,
Chair.
[FR Doc. 2011–18931 Filed 7–26–11; 8:45 am]
BILLING CODE 2210–40–P
DEPARTMENT OF VETERANS
AFFAIRS
[OMB Control No. 2900–New; DBQs—Group
4]
Proposed Information Collection
(Disability Benefits Questionnaires—
Group 4) Activity: Comment Request
. Department of Veterans
Affairs, Veterans Benefits
Administration
ACTION: Notice.
AGENCY:
The Veterans Benefits
Administration (VBA), Department of
Veterans Affairs (VA), is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act (PRA) of
1995, Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
new collection and allow 60 days for
public comment in response to the
notice. This notice solicits comments for
information needed to obtain medical
SUMMARY:
E:\FR\FM\27JYN1.SGM
27JYN1
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 144 / Wednesday, July 27, 2011 / Notices
evidence to adjudicate a claim for
disability benefits.
DATES: Written comments and
recommendations on the proposed
collection of information should be
received on or before September 26,
2011.
ADDRESSES: Submit written comments
on the collection of information through
Federal Docket Management System
(FDMS) at https://www.Regulations.gov
or to Nancy J. Kessinger, Veterans
Benefits Administration (20M33),
Department of Veterans Affairs, 810
Vermont Avenue, NW., Washington, DC
20420 or e-mail to
nancy.kessinger@va.gov. Please refer to
‘‘OMB Control No. 2900–New (DBQs—
Group 4)’’ in any correspondence.
During the comment period, comments
may be viewed online through FDMS.
FOR FURTHER INFORMATION CONTACT:
Nancy J. Kessinger at (202) 461–9769 or
Fax (202) 275–5947.
SUPPLEMENTARY INFORMATION: Under the
PRA of 1995 (Pub. L. 104–13; 44 U.S.C.
3501–3521), Federal agencies must
obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. This request for comment is
being made pursuant to Section
3506(c)(2)(A) of the PRA.
With respect to the following
collection of information, VBA invites
comments on: (1) Whether the proposed
collection of information is necessary
for the proper performance of VBA’s
functions, including whether the
information will have practical utility;
(2) the accuracy of VBA’s estimate of the
burden of the proposed collection of
information; (3) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
the use of other forms of information
technology.
Titles:
a. Cranial Nerves Diseases Disability
Benefits Questionnaire, VA Form 21–
0960C3.
b. Narcolepsy Disability Benefits
Questionnaire, VA Form 21–0960C6.
c. Fibromyalgia Disability Benefits
Questionnaire, VA Form 21–0960C7.
d. Seizure Disorders (Epilepsy)
Disability Benefits Questionnaire, VA
Form 21–0960C11.
VerDate Mar<15>2010
17:08 Jul 26, 2011
Jkt 223001
e. Oral and Dental including Mouth,
Lips, and Tongue (other than
Temporomandibular Joint Conditions)
Disability Benefits Questionnaire, VA
Form 21–0960D1.
f. Endocrine Diseases (other than
Thyroid, Parathyroid or Diabetes
Mellitus) Disability Benefits
Questionnaire, VA Form 21–0960–E–2.
g. Thyroid & Parathyroid Conditions
Disability Benefits Questionnaire, VA
Form 21–0960–E–3.
h. Abdominal, Inguinal, and Femoral
Hernias Disability Benefits
Questionnaire, VA Form 21–0960–H–1.
i. HIV-Related Illnesses Disability
Benefits Questionnaire, VA Form 21–
0960–I–2 .
j. Infectious Diseases Other Than HIVRelated Illness, Chronic Fatigue
Syndrome, and Tuberculosis Disability
Benefits Questionnaire, VA Form 21–
0960–I–3.
k. Systemic Lupus Erytematous (SLE)
and Other Immune Disorders (except
HIV) and Other Autoimmune Diseases
(other than HIV and Diabetes Mellitus
Type I) Disability Benefits
Questionnaire, VA Form 21–0960–I–4.
l. Nutritional Deficiencies Disability
Benefits Questionnaire, VA Form 21–
0960–I–5.
m. Urinary Tract (including Bladder &
Urethra) Conditions (excluding Male
Reproductive System) Disability
Benefits Questionnaire, VA Form 21–
0960–J–4.
n. Respiratory Conditions (other than
Tuberculosis and Sleep Apnea)
Disability Benefits Questionnaire, VA
Form 21–0960–L–1.
o. Loss of Sense of Smell and/or Taste
Disability Benefits Questionnaire, VA
Form 21–0960–N–3.
p. Sinusitis/Rhinitis and Other
Conditions of the Nose, Throat, Larynx,
and Pharynx Disability Benefits
Questionnaire, VA Form 21–0960–N–4.
q. Chronic Fatigue Syndrome
Disability Benefits Questionnaire, VA
Form 21–0960–Q–1.
OMB Control Number: 2900–New
(DBQs—Group 4).
Type of Review: New collection.
Abstract: Data collected on VA Form
21–0960 series will be used to obtain
information from claimants treating
physician that is necessary to adjudicate
a claim for disability benefits.
Affected Public: Individuals or
households.
Estimated Annual Burden:
a. VAF 21–0960–C–3—5,000.
PO 00000
Frm 00122
Fmt 4703
Sfmt 9990
45009
b. VAF 21–0960–C–6—1,250.
c. VAF 21–0960–C–7—1,250.
d. VAF 21–0960–C–11—1,250.
e. VAF 21–0960–D–1—1,250.
f. VAF 21–0960–E–2—2,500.
g. VAF 21–0960–E–3—2,500.
h. VAF 21–0960–H–1—3,750.
i. VAF 21–0960–I–2—1,250.
j. VAF 21–0960–I–3—2,500.
k. VAF 21–0960–I–4—2,500.
l. VAF 21–0960–I–5—1,250.
m. VAF 21–0960–J–4—3,750.
n. VAF 21–0960–L–1—10,000.
o. VAF 21–0960–N–3—1,250.
p. VAF 21–0960–N–4—10,000.
q. VAF 21–0960–Q–1—2,500.
Estimated Average Burden per
Respondent:
a. VAF 21–0960–C–3—30 minutes.
b. VAF 21–0960–C–6—15 minutes.
c. VAF 21–0960–C–7—15 minutes.
d. VAF 21–0960–C–11—15 minutes.
e. VAF 21–0960–D–1—15 minutes.
f. VAF 21–0960–E–2—15 minutes.
g. VAF 21–0960–E–3—15 minutes.
h. VAF 21–0960–H–1—15 minutes.
i. VAF 21–0960–I–2—15 minutes.
j. VAF 21–0960–I–3—15 minutes.
k. VAF 21–0960–I–4—30 minutes.
l. VAF 21–0960–I–5—15 minutes.
m. VAF 21–0960–J–4—15 minutes.
n. VAF 21–0960–L–1—30 minutes.
o. VAF 21–0960–N–3—15 minutes.
p. VAF 21–0960–N–4—30 minutes.
q. VAF 21–0960–Q–1—15 minutes.
Frequency of Response: On occasion.
Estimated Number of Respondents:
a. VAF 21–0960–C–3—10,000.
b. VAF 21–0960–C–6—5,000.
c. VAF 21–0960–C–7—5,000.
d. VAF 21–0960–C–11—5,000.
e. VAF 21–0960–D–1—5,000.
f. VAF 21–0960–E–2—10,000.
g. VAF 21–0960–E–3—10,000.
h. VAF 21–0960–H–1—15,000.
i. VAF 21–0960–I–2—5,000.
j. VAF 21–0960–I–3—10,000.
k. VAF 21–0960–I–4—5,000.
l. VAF 21–0960–I–5—5,000.
m. VAF 21–0960–J–4—15,000.
n. VAF 21–0960–L–1—20,000.
o. VAF 21–0960–N–3—5,000.
p. VAF 21–0960–N–4—20,000.
q. VAF 21–0960–Q–1—10,000.
Dated: July 22, 2011.
By direction of the Secretary.
Denise McLamb,
Program Analyst, Enterprise Records Service.
[FR Doc. 2011–18958 Filed 7–26–11; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\27JYN1.SGM
27JYN1
]]>Agencies
[Federal Register Volume 76, Number 144 (Wednesday, July 27, 2011)]
[Notices]
[Pages 45008-45009]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18958]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
[OMB Control No. 2900-New; DBQs--Group 4]
Proposed Information Collection (Disability Benefits
Questionnaires--Group 4) Activity: Comment Request
AGENCY: . Department of Veterans Affairs, Veterans Benefits
Administration
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Veterans Benefits Administration (VBA), Department of
Veterans Affairs (VA), is announcing an opportunity for public comment
on the proposed collection of certain information by the agency. Under
the Paperwork Reduction Act (PRA) of 1995, Federal agencies are
required to publish notice in the Federal Register concerning each
proposed collection of information, including each proposed new
collection and allow 60 days for public comment in response to the
notice. This notice solicits comments for information needed to obtain
medical
[[Page 45009]]
evidence to adjudicate a claim for disability benefits.
DATES: Written comments and recommendations on the proposed collection
of information should be received on or before September 26, 2011.
ADDRESSES: Submit written comments on the collection of information
through Federal Docket Management System (FDMS) at https://www.Regulations.gov or to Nancy J. Kessinger, Veterans Benefits
Administration (20M33), Department of Veterans Affairs, 810 Vermont
Avenue, NW., Washington, DC 20420 or e-mail to nancy.kessinger@va.gov.
Please refer to ``OMB Control No. 2900-New (DBQs--Group 4)'' in any
correspondence. During the comment period, comments may be viewed
online through FDMS.
FOR FURTHER INFORMATION CONTACT: Nancy J. Kessinger at (202) 461-9769
or Fax (202) 275-5947.
SUPPLEMENTARY INFORMATION: Under the PRA of 1995 (Pub. L. 104-13; 44
U.S.C. 3501-3521), Federal agencies must obtain approval from the
Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. This request for comment is being
made pursuant to Section 3506(c)(2)(A) of the PRA.
With respect to the following collection of information, VBA
invites comments on: (1) Whether the proposed collection of information
is necessary for the proper performance of VBA's functions, including
whether the information will have practical utility; (2) the accuracy
of VBA's estimate of the burden of the proposed collection of
information; (3) ways to enhance the quality, utility, and clarity of
the information to be collected; and (4) ways to minimize the burden of
the collection of information on respondents, including through the use
of automated collection techniques or the use of other forms of
information technology.
Titles:
a. Cranial Nerves Diseases Disability Benefits Questionnaire, VA
Form 21-0960C3.
b. Narcolepsy Disability Benefits Questionnaire, VA Form 21-0960C6.
c. Fibromyalgia Disability Benefits Questionnaire, VA Form 21-
0960C7.
d. Seizure Disorders (Epilepsy) Disability Benefits Questionnaire,
VA Form 21-0960C11.
e. Oral and Dental including Mouth, Lips, and Tongue (other than
Temporomandibular Joint Conditions) Disability Benefits Questionnaire,
VA Form 21-0960D1.
f. Endocrine Diseases (other than Thyroid, Parathyroid or Diabetes
Mellitus) Disability Benefits Questionnaire, VA Form 21-0960-E-2.
g. Thyroid & Parathyroid Conditions Disability Benefits
Questionnaire, VA Form 21-0960-E-3.
h. Abdominal, Inguinal, and Femoral Hernias Disability Benefits
Questionnaire, VA Form 21-0960-H-1.
i. HIV-Related Illnesses Disability Benefits Questionnaire, VA Form
21-0960-I-2 .
j. Infectious Diseases Other Than HIV-Related Illness, Chronic
Fatigue Syndrome, and Tuberculosis Disability Benefits Questionnaire,
VA Form 21-0960-I-3.
k. Systemic Lupus Erytematous (SLE) and Other Immune Disorders
(except HIV) and Other Autoimmune Diseases (other than HIV and Diabetes
Mellitus Type I) Disability Benefits Questionnaire, VA Form 21-0960-I-
4.
l. Nutritional Deficiencies Disability Benefits Questionnaire, VA
Form 21-0960-I-5.
m. Urinary Tract (including Bladder & Urethra) Conditions
(excluding Male Reproductive System) Disability Benefits Questionnaire,
VA Form 21-0960-J-4.
n. Respiratory Conditions (other than Tuberculosis and Sleep Apnea)
Disability Benefits Questionnaire, VA Form 21-0960-L-1.
o. Loss of Sense of Smell and/or Taste Disability Benefits
Questionnaire, VA Form 21-0960-N-3.
p. Sinusitis/Rhinitis and Other Conditions of the Nose, Throat,
Larynx, and Pharynx Disability Benefits Questionnaire, VA Form 21-0960-
N-4.
q. Chronic Fatigue Syndrome Disability Benefits Questionnaire, VA
Form 21-0960-Q-1.
OMB Control Number: 2900-New (DBQs--Group 4).
Type of Review: New collection.
Abstract: Data collected on VA Form 21-0960 series will be used to
obtain information from claimants treating physician that is necessary
to adjudicate a claim for disability benefits.
Affected Public: Individuals or households.
Estimated Annual Burden:
a. VAF 21-0960-C-3--5,000.
b. VAF 21-0960-C-6--1,250.
c. VAF 21-0960-C-7--1,250.
d. VAF 21-0960-C-11--1,250.
e. VAF 21-0960-D-1--1,250.
f. VAF 21-0960-E-2--2,500.
g. VAF 21-0960-E-3--2,500.
h. VAF 21-0960-H-1--3,750.
i. VAF 21-0960-I-2--1,250.
j. VAF 21-0960-I-3--2,500.
k. VAF 21-0960-I-4--2,500.
l. VAF 21-0960-I-5--1,250.
m. VAF 21-0960-J-4--3,750.
n. VAF 21-0960-L-1--10,000.
o. VAF 21-0960-N-3--1,250.
p. VAF 21-0960-N-4--10,000.
q. VAF 21-0960-Q-1--2,500.
Estimated Average Burden per Respondent:
a. VAF 21-0960-C-3--30 minutes.
b. VAF 21-0960-C-6--15 minutes.
c. VAF 21-0960-C-7--15 minutes.
d. VAF 21-0960-C-11--15 minutes.
e. VAF 21-0960-D-1--15 minutes.
f. VAF 21-0960-E-2--15 minutes.
g. VAF 21-0960-E-3--15 minutes.
h. VAF 21-0960-H-1--15 minutes.
i. VAF 21-0960-I-2--15 minutes.
j. VAF 21-0960-I-3--15 minutes.
k. VAF 21-0960-I-4--30 minutes.
l. VAF 21-0960-I-5--15 minutes.
m. VAF 21-0960-J-4--15 minutes.
n. VAF 21-0960-L-1--30 minutes.
o. VAF 21-0960-N-3--15 minutes.
p. VAF 21-0960-N-4--30 minutes.
q. VAF 21-0960-Q-1--15 minutes.
Frequency of Response: On occasion.
Estimated Number of Respondents:
a. VAF 21-0960-C-3--10,000.
b. VAF 21-0960-C-6--5,000.
c. VAF 21-0960-C-7--5,000.
d. VAF 21-0960-C-11--5,000.
e. VAF 21-0960-D-1--5,000.
f. VAF 21-0960-E-2--10,000.
g. VAF 21-0960-E-3--10,000.
h. VAF 21-0960-H-1--15,000.
i. VAF 21-0960-I-2--5,000.
j. VAF 21-0960-I-3--10,000.
k. VAF 21-0960-I-4--5,000.
l. VAF 21-0960-I-5--5,000.
m. VAF 21-0960-J-4--15,000.
n. VAF 21-0960-L-1--20,000.
o. VAF 21-0960-N-3--5,000.
p. VAF 21-0960-N-4--20,000.
q. VAF 21-0960-Q-1--10,000.
Dated: July 22, 2011.
By direction of the Secretary.
Denise McLamb,
Program Analyst, Enterprise Records Service.
[FR Doc. 2011-18958 Filed 7-26-11; 8:45 am]
BILLING CODE 8320-01-P
